https://www.nasdaq.com/press-release/aptose-to-participate-in-two-biotech-events-in-january-2022-2021-12-29
https://www.nasdaq.com/press-release/aptose-provides-update-on-apto-253-program-2021-12-20
https://www.nasdaq.com/press-release/hm43239-demonstrates-durable-clinical-benefit-in-acute-myeloid-leukemia-2021-12-13
https://www.nasdaq.com/press-release/aptose-to-hold-corporate-update-monday-december-13th-2021-11-29
https://www.nasdaq.com/press-release/aptose-to-present-at-the-piper-sandler-33rd-annual-healthcare-conference-2021-11-22
https://www.nasdaq.com/press-release/aptose-reports-results-for-the-third-quarter-2021-2021-11-11
https://www.nasdaq.com/press-release/aptose-clinical-data-to-be-presented-at-the-2021-ash-annual-meeting-2021-11-04
https://www.nasdaq.com/press-release/aptose-enters-into-exclusive-worldwide-license-agreement-with-hanmi-pharmaceutical
https://www.nasdaq.com/press-release/aptose-to-report-third-quarter-2021-financial-results-and-hold-conference-call-on
https://www.nasdaq.com/press-release/aptose-expands-senior-leadership-team-2021-10-25
https://www.nasdaq.com/press-release/aptose-to-present-at-september-investor-conferences-2021-08-30
https://www.nasdaq.com/press-release/aptose-reports-results-for-the-second-quarter-2021-2021-08-03
https://www.nasdaq.com/press-release/aptose-to-report-second-quarter-2021-financial-results-and-hold-conference-call-on
https://www.nasdaq.com/press-release/aptose-presents-highlights-from-eha-during-corporate-update-event-2021-06-11
https://www.nasdaq.com/press-release/aptose-biosciences-announces-results-of-annual-meeting-of-shareholders-2021-06-01
https://www.nasdaq.com/press-release/aptose-to-hold-corporate-update-friday-june-11th-2021-05-27
https://www.nasdaq.com/press-release/aptose-to-present-at-upcoming-investor-conferences-2021-05-13
https://www.nasdaq.com/press-release/aptose-reports-results-for-the-first-quarter-2021-2021-05-04
https://www.nasdaq.com/press-release/aptose-to-report-first-quarter-2021-financial-results-and-hold-conference-call-on
https://www.nasdaq.com/press-release/aptose-to-present-at-canaccord-genuity-2021-horizons-in-oncology-virtual-conference
https://www.nasdaq.com/press-release/aptose-reports-results-for-the-fourth-quarter-and-full-year-2020-2021-03-23
https://www.nasdaq.com/press-release/aptose-expands-senior-leadership-team-2021-03-16
https://www.nasdaq.com/press-release/aptose-to-release-fourth-quarter-and-year-end-december-31-2020-financial-results-and
https://www.nasdaq.com/press-release/aptose-presents-highlights-from-ash-and-corporate-update-event-2020-12-06
https://www.nasdaq.com/press-release/aptose-to-hold-corporate-update-sunday-december-6th-2020-12-01
https://www.nasdaq.com/press-release/aptose-reports-results-for-the-third-quarter-2020-2020-11-10
https://www.nasdaq.com/press-release/aptose-to-present-cg-806-and-apto-253-data-at-the-2020-ash-annual-meeting-2020-11-04
https://www.nasdaq.com/press-release/aptose-to-release-third-quarter-ended-september-30-2020-financial-results-and-hold
https://www.nasdaq.com/press-release/aptose-initiates-dosing-of-cg-806-in-patients-with-acute-myeloid-leukemia-2020-10-19
https://www.nasdaq.com/press-release/aptose-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-summit-2020-09
https://www.nasdaq.com/press-release/aptose-to-present-at-september-investor-conferences-2020-09-09
https://www.nasdaq.com/press-release/aptose-biosciences-to-present-at-canaccord-genuity-40th-annual-growth-conference-2020
https://www.nasdaq.com/press-release/aptose-reports-results-for-the-second-quarter-2020-2020-08-04
https://www.nasdaq.com/press-release/aptose-to-release-second-quarter-ended-june-30-2020-financial-results-and-hold
https://www.nasdaq.com/press-release/aptose-announces-pricing-of-public-offering-of-common-shares-2020-07-15
https://www.nasdaq.com/press-release/aptose-announces-proposed-public-offering-of-common-shares-2020-07-15
https://www.nasdaq.com/press-release/aptose-announces-fda-allowance-of-ind-for-phase-1a-b-study-of-cg-806-in-acute-myeloid
https://www.nasdaq.com/press-release/aptose-presents-early-phase-1a-b-cg-806-clinical-findings-at-the-25th-congress-of-the
https://www.nasdaq.com/press-release/aptose-biosciences-announces-results-of-annual-meeting-of-shareholders-2020-06-02
https://www.nasdaq.com/press-release/aptose-to-present-early-cg-806-clinical-findings-at-the-25th-congress-of-the-european
https://www.nasdaq.com/press-release/aptose-to-present-at-2020-rbc-capital-markets-global-healthcare-virtual-conference
https://www.nasdaq.com/press-release/aptose-biosciences-establishes-new-at-the-market-facility-2020-05-05
https://www.nasdaq.com/press-release/aptose-reports-results-for-the-first-quarter-2020-2020-05-05
https://www.nasdaq.com/press-release/aptose-presents-preliminary-clinical-data-on-cg-806-at-aacr-virtual-annual-meeting
https://www.nasdaq.com/press-release/aptose-biosciences-files-proxy-statement-announces-online-only-annual-general-meeting
https://www.nasdaq.com/press-release/aptose-to-release-first-quarter-ended-march-31-2020-financial-results-and-hold
https://www.nasdaq.com/press-release/aptose-reports-results-for-the-fourth-quarter-and-full-year-2019-2020-03-10
https://www.nasdaq.com/press-release/aptose-to-release-fourth-quarter-and-year-end-december-31-2019-financial-results-and
https://www.nasdaq.com/press-release/aptose-biosciences-to-host-key-opinion-leader-event-present-at-bio-ceo-investor
https://www.nasdaq.com/press-release/aptose-biosciences-to-present-at-biotech-showcasetm-2020-conference-2020-01-07
https://www.nasdaq.com/press-release/aptose-announces-closing-of-public-offering-of-common-shares-2019-12-19
https://www.nasdaq.com/press-release/aptose-announces-pricing-of-public-offering-of-common-shares-2019-12-17
https://www.nasdaq.com/press-release/aptose-announces-proposed-public-offering-of-common-shares-2019-12-16
https://www.nasdaq.com/press-release/aptose-presents-new-preclinical-cg-806-data-at-the-2019-ash-annual-meeting-2019-12-09
https://www.nasdaq.com/press-release/aptose-presents-highlights-from-corporate-event-at-ash-2019-12-07
https://www.nasdaq.com/press-release/aptose-appoints-rafael-bejar-m.d.-ph.d.-as-chief-medical-officer-2019-12-04
https://www.nasdaq.com/press-release/aptose-to-present-at-31st-annual-piper-jaffray-healthcare-conference-2019-12-02
https://www.nasdaq.com/press-release/aptose-to-present-at-bio-europe-conference-2019-11-07
https://www.nasdaq.com/press-release/aptose-to-present-new-cg-806-data-at-the-2019-ash-annual-meeting-2019-11-06
https://www.nasdaq.com/press-release/aptose-reports-results-for-the-third-quarter-ended-september-30-2019-2019-11-05
https://www.nasdaq.com/press-release/aptose-to-release-third-quarter-ended-september-30-2019-financial-results-and-hold
https://www.nasdaq.com/press-release/aptose-to-participate-at-5th-international-conference-on-acute-myeloid-leukemia-of
https://www.nasdaq.com/press-release/aptose-to-participate-in-oppenheimer-fall-summit-focused-on-specialty-pharma-and-rare
https://www.nasdaq.com/press-release/aptose-reports-results-fourth-quarter-and-year-ended-december-31-2018-2019-04-11
